Transforming Laboratory Diagnostics with AI – Qritive at Medlab Middle East 2025

Singapore, February 10, 2025 — Qritive participated in Medlab Middle East 2025, held from February 3–5 at the Dubai World Trade Centre, where we showcased the transformative role of AI in cancer diagnostics.

Our team presented how our AI-powered digital pathology solutions can support pathologists and laboratories in improving diagnostic accuracy, efficiency, and workflow consistency. Live demonstrations at our booth provided attendees with real-world insights into the impact of AI on pathology practices.

Medlab Middle East continues to be a key event for professionals in the medical laboratory field, and we were pleased to engage with stakeholders, explore collaborative opportunities, and share our innovations with the broader diagnostic community.

We thank the organizers and visitors who connected with us during the event and look forward to continued conversations on advancing AI in diagnostic care.

About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com.